Literature DB >> 18219520

Significance of perivascular soft tissue around the common hepatic and proximal superior mesenteric arteries arising after pancreaticoduodenectomy: evaluation with serial MDCT studies.

Kousei Ishigami1, Kengo Yoshimitsu, Hiroyuki Irie, Tsuyoshi Tajima, Yoshiki Asayama, Masakazu Hirakawa, Daisuke Kakihara, Yoshiyuki Shioyama, Yunosuke Nishihara, Koji Yamaguchi, Hiroshi Honda.   

Abstract

PURPOSE: To evaluate the interval change of perivascular soft tissue (PVST) around the common hepatic and proximal superior mesenteric arteries arising after pancreaticoduodenectomy (PD) and to compare the difference between post operative change (benign PVST) and recurrence (malignant PVST).
MATERIALS AND METHODS: Serial multidetector CT (MDCT) studies in 44 patients who underwent PD for periampullary carcinomas were retrospectively reviewed (Group A). The incidence and interval change of PVST were evaluated and compared to control group (Group B, 21 patients with PD for benign diseases).
RESULTS: PVST was seen in all the 44 patients in Group A, and it was noted in 12 of 21 (57.1%) patients in Group B. Thirteen of 44 (29.5%) patients showed interval enlargement of PVST (malignant PVST), and 12 of 13 developed within 2 years after PD. There was higher incidence of malignant PVST in patients with lymph node metastasis (p < 0.01) and those with pancreas head carcinoma (p < 0.05).
CONCLUSION: PVST is common after PD regardless of whether patients had malignant or benign diseases. PVST should be monitored for at least 2 years to distinguish recurrence from post operative change. Patients with lymph node metastasis and pancreas head carcinoma had a higher incidence of malignant PVST.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18219520     DOI: 10.1007/s00261-008-9359-9

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  6 in total

1.  CT diagnosis of recurrence after pancreatic cancer: is there a pattern?

Authors:  Tobias Heye; Nicola Zausig; Miriam Klauss; Reinhard Singer; Jens Werner; Götz Martin Richter; Hans-Ulrich Kauczor; Lars Grenacher
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

2.  Preoperative diagnosis of lymph node metastasis in biliary and pancreatic carcinomas: evaluation of the combination of multi-detector CT and serum CA19-9 level.

Authors:  Atsushi Nanashima; Ichiro Sakamoto; Tomayoshi Hayashi; Syuuichi Tobinaga; Masato Araki; Masaki Kunizaki; Takashi Nonaka; Hiroaki Takeshita; Shigekazu Hidaka; Terumitsu Sawai; Toru Yasutake; Takeshi Nagayasu
Journal:  Dig Dis Sci       Date:  2010-03-18       Impact factor: 3.199

3.  Multimodality treatment of recurrent pancreatic cancer: Mith or reality?

Authors:  Cosimo Sperti; Lucia Moletta; Stefano Merigliano
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

4.  Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of abdominal radiology disease focus panel on PDAC.

Authors:  Linda C Chu; Zhen J Wang; Avinash Kambadakone; Elizabeth M Hecht; Jin He; Amol K Narang; Daniel A Laheru; Hina Arif-Tiwari; Priya Bhosale; Candice W Bolan; Olga R Brook; Abraham F Bezuidenhout; Richard K G Do; Samuel J Galgano; Ajit H Goenka; Alexander R Guimaraes; David M Hough; Naveen Kulkarni; Ott Le; Lyndon Luk; Lorenzo Mannelli; Michael Rosenthal; Guillermo Sangster; Zarine K Shah; Erik V Soloff; Parag P Tolat; Marc Zins; Elliot K Fishman; Eric P Tamm; Atif Zaheer
Journal:  Abdom Radiol (NY)       Date:  2022-10-14

Review 5.  Elucidating early CT after pancreatico-duodenectomy: a primer for radiologists.

Authors:  Massimo Tonolini; Anna Maria Ierardi; Gianpaolo Carrafiello
Journal:  Insights Imaging       Date:  2018-04-13

Review 6.  Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayesian network meta-analysis.

Authors:  Victor Hugo Fonseca de Jesus; Rachel P Riechelmann
Journal:  Ecancermedicalscience       Date:  2021-08-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.